These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 11857271

  • 1. Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein.
    Grégoire C, Péloponèse JM, Esquieu D, Opi S, Campbell G, Solomiac M, Lebrun E, Lebreton J, Loret EP.
    Biopolymers; 2001; 62(6):324-35. PubMed ID: 11857271
    [Abstract] [Full Text] [Related]

  • 2. Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant.
    Watkins JD, Campbell GR, Halimi H, Loret EP.
    Retrovirology; 2008 Sep 22; 5():83. PubMed ID: 18808674
    [Abstract] [Full Text] [Related]

  • 3. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE, Greenwood JD, Williamson JC, Derse D, Pallansch LA, Copeland T, Rasmussen L, Mentzer A, Nagashima K, Tobin G, Gonda MA.
    Virology; 1997 Jul 07; 233(2):339-57. PubMed ID: 9217057
    [Abstract] [Full Text] [Related]

  • 4. Comparative analysis of HIV-1 Tat variants.
    Pantano S, Carloni P.
    Proteins; 2005 Feb 15; 58(3):638-43. PubMed ID: 15609368
    [Abstract] [Full Text] [Related]

  • 5. Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1.
    Reddy MV, Desai M, Jeyapaul J, Prasad DD, Seshamma T, Palmeri D, Khan SA.
    Oncogene; 1992 Sep 15; 7(9):1743-8. PubMed ID: 1501886
    [Abstract] [Full Text] [Related]

  • 6. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.
    Rappaport J, Lee SJ, Khalili K, Wong-Staal F.
    New Biol; 1989 Oct 15; 1(1):101-10. PubMed ID: 2562188
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y, Solis M, Sun Q, Grandvaux N, Van Lint C, Burny A, Gatignol A, Wainberg MA, Lin R, Hiscott J.
    J Virol; 2005 Jul 15; 79(14):9180-91. PubMed ID: 15994812
    [Abstract] [Full Text] [Related]

  • 10. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H, Tamilarasu N, Rana TM.
    Bioconjug Chem; 2006 Jul 15; 17(2):352-8. PubMed ID: 16536465
    [Abstract] [Full Text] [Related]

  • 11. 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein.
    Péloponèse JM, Grégoire C, Opi S, Esquieu D, Sturgis J, Lebrun E, Meurs E, Collette Y, Olive D, Aubertin AM, Witvrow M, Pannecouque C, De Clercq E, Bailly C, Lebreton J, Loret EP.
    C R Acad Sci III; 2000 Oct 15; 323(10):883-94. PubMed ID: 11098404
    [Abstract] [Full Text] [Related]

  • 12. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans.
    Buttò S, Fiorelli V, Tripiciano A, Ruiz-Alvarez MJ, Scoglio A, Ensoli F, Ciccozzi M, Collacchi B, Sabbatucci M, Cafaro A, Guzmán CA, Borsetti A, Caputo A, Vardas E, Colvin M, Lukwiya M, Rezza G, Ensoli B, Tat Multicentric Study Group.
    J Infect Dis; 2003 Oct 15; 188(8):1171-80. PubMed ID: 14551888
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
    Long KS, Crothers DM.
    Biochemistry; 1999 Aug 03; 38(31):10059-69. PubMed ID: 10433713
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
    Roof P, Ricci M, Genin P, Montano MA, Essex M, Wainberg MA, Gatignol A, Hiscott J.
    Virology; 2002 Apr 25; 296(1):77-83. PubMed ID: 12036319
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Furin cleavage of the HIV-1 Tat protein.
    Tikhonov I, Ruckwardt TJ, Berg S, Hatfield GS, David Pauza C.
    FEBS Lett; 2004 May 07; 565(1-3):89-92. PubMed ID: 15135058
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
    Arya SK.
    AIDS Res Hum Retroviruses; 1993 Sep 07; 9(9):839-48. PubMed ID: 8257633
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Full-length HIV-1 Tat protein necessary for a vaccine.
    Opi S, Péloponèse JM, Esquieu D, Watkins J, Campbell G, De Mareuil J, Jeang KT, Yirrell DL, Kaleebu P, Loret EP.
    Vaccine; 2004 Aug 13; 22(23-24):3105-11. PubMed ID: 15297062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.